OLEMA PHARMACEUTICALS INC. - COMMON STOCK

Olema Oncology Announces Upcoming Clinical Data Poster Presentation at the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

12 Oct 2022 06:01:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 Oct 2022 15:29:00 By Nasdaq GlobeNewswire

Olema Oncology to Present at H.C. Wainwright 24th Annual Global Investment Conference

06 Sep 2022 15:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 Sep 2022 16:01:48 By Nasdaq GlobeNewswire

Olema Oncology Reports Second Quarter 2022 Financial Results and Provides Corporate Update

09 Aug 2022 15:35:00 By Nasdaq GlobeNewswire

Olema Oncology Advances OP-1250 into Phase 2 Monotherapy Expansion in Patients with ER+/HER2- Advanced Breast Cancer

09 Aug 2022 15:30:00 By Nasdaq GlobeNewswire

Olema Oncology to Present at Canaccord Genuity 42nd Annual Growth Conference

04 Aug 2022 15:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 Aug 2022 15:30:00 By Nasdaq GlobeNewswire

Olema Oncology Receives FDA Fast Track Designation for OP-1250 for the Treatment of ER+ / HER2- Metastatic Breast Cancer

21 Jul 2022 06:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 Jul 2022 15:30:00 By Nasdaq GlobeNewswire

Olema Oncology Provides Clinical Update Reflecting Strong Progress Across OP-1250 Development Program

09 Jun 2022 06:35:00 By Nasdaq GlobeNewswire

Olema Oncology and Aurigene Announce Exclusive Collaboration and License Agreement to Discover and Develop Novel Cancer Therapies

09 Jun 2022 06:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 Jun 2022 15:30:00 By Nasdaq GlobeNewswire

Olema Oncology to Present at Jefferies Healthcare Conference

24 May 2022 15:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports First Quarter 2022 Financial Results and Provides Corporate Update

09 May 2022 15:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 May 2022 15:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

18 Apr 2022 15:30:00 By Nasdaq GlobeNewswire

Olema Oncology to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

04 Apr 2022 06:30:00 By Nasdaq GlobeNewswire

Olema Oncology Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2022

08 Mar 2022 15:35:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

28 Feb 2022 15:30:00 By Nasdaq GlobeNewswire